$OCUL Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in OCULAR THERAPEUTIX, INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in OCULAR THERAPEUTIX, INC. Get notifications about new insider transactions in OCULAR THERAPEUTIX, INC for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 12 2015 | OCUL | OCULAR THERAPEUTIX ... | GARVEY JAMES M | Director | Option Exercise | A | 22.54 | 5,681 | 128,050 | 5,681 | |
Jun 11 2015 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Sell | S | 22.00 | 10,297 | 226,534 | 61,084 | 71.4 K to 61.1 K (-14.43 %) |
Jun 11 2015 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Sell | S | 22.00 | 362,703 | 7,979,466 | 2,151,523 | 2.5 M to 2.2 M (-14.43 %) |
Jun 11 2015 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Sell | S | 22.00 | 373,000 | 8,206,000 | 2,212,607 | 2.6 M to 2.2 M (-14.43 %) |
Jun 11 2015 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Sell | S | 22.00 | 373,000 | 8,206,000 | 2,212,607 | 2.6 M to 2.2 M (-14.43 %) |
Jun 11 2015 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Sell | S | 22.00 | 2,506 | 55,132 | 14,885 | 17.4 K to 14.9 K (-14.41 %) |
Jun 11 2015 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Sell | S | 22.00 | 424,494 | 9,338,868 | 2,520,499 | 2.9 M to 2.5 M (-14.41 %) |
Jun 11 2015 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Sell | S | 22.00 | 2,506 | 55,132 | 14,885 | 17.4 K to 14.9 K (-14.41 %) |
Jun 11 2015 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Sell | S | 22.00 | 424,494 | 9,338,868 | 2,520,499 | 2.9 M to 2.5 M (-14.41 %) |
May 15 2015 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Option Exercise | M | 1.35 | 51,491 | 69,513 | 58,357 | |
May 15 2015 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | M | 1.35 | 51,491 | 69,513 | 538,733 | 487.2 K to 538.7 K (+10.57 %) |
Apr 01 2015 | OCUL | OCULAR THERAPEUTIX ... | LINDSTROM RICHARD L MD | Director | Option Exercise | M | 0.96 | 5,681 | 5,454 | 0 | |
Apr 01 2015 | OCUL | OCULAR THERAPEUTIX ... | LINDSTROM RICHARD L MD | Director | Option Exercise | M | 0.14 | 18,939 | 2,651 | 0 | |
Apr 01 2015 | OCUL | OCULAR THERAPEUTIX ... | LINDSTROM RICHARD L MD | Director | Buy | M | 0.96 | 5,681 | 5,454 | 43,559 | 37.9 K to 43.6 K (+15.00 %) |
Apr 01 2015 | OCUL | OCULAR THERAPEUTIX ... | LINDSTROM RICHARD L MD | Director | Buy | M | 0.14 | 18,939 | 2,651 | 37,878 | 18.9 K to 37.9 K (+100.00 %) |
Mar 06 2015 | OCUL | OCULAR THERAPEUTIX ... | Ankerud Eric | See Remarks | Buy | P | 13.00 | 1,000 | 13,000 | 78,651 | 77.7 K to 78.7 K (+1.29 %) |
Feb 05 2015 | OCUL | OCULAR THERAPEUTIX ... | Smith W Bradford | CFO and Treasurer | Option Exercise | A | 30.07 | 55,000 | 1,653,850 | 55,000 | |
Feb 05 2015 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Option Exercise | A | 30.07 | 170,000 | 5,111,900 | 170,000 | |
Feb 05 2015 | OCUL | OCULAR THERAPEUTIX ... | Ankerud Eric | See Remarks | Option Exercise | A | 30.07 | 45,000 | 1,353,150 | 45,000 | |
Feb 05 2015 | OCUL | OCULAR THERAPEUTIX ... | Fortune James | Chief Operating Off ... | Option Exercise | A | 30.07 | 79,000 | 2,375,530 | 79,000 | |
Feb 04 2015 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 29.50 | 4,824 | 142,308 | 19,588 | 24.4 K to 19.6 K (-19.76 %) |
Feb 04 2015 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 29.50 | 3,304 | 97,468 | 13,419 | 16.7 K to 13.4 K (-19.76 %) |
Feb 04 2015 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 29.50 | 9,403 | 277,389 | 38,178 | 47.6 K to 38.2 K (-19.76 %) |
Feb 04 2015 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Sell | S | 29.50 | 482,469 | 14,232,836 | 1,958,824 | 2.4 M to 2 M (-19.76 %) |
Sep 02 2014 | OCUL | OCULAR THERAPEUTIX ... | PEACOCK BRUCE | Director | Option Exercise | A | 15.80 | 11,363 | 179,535 | 11,363 | |
Aug 08 2014 | OCUL | OCULAR THERAPEUTIX ... | CHV II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 252,525 | 0 | 0 | |
Aug 08 2014 | OCUL | OCULAR THERAPEUTIX ... | CHV II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 1,693,767 | 0 | 0 | |
Aug 08 2014 | OCUL | OCULAR THERAPEUTIX ... | CHV II, L.P. | 10% Owner | Buy | P | 13.00 | 153,846 | 1,999,998 | 2,100,138 | 1.9 M to 2.1 M (+7.90 %) |
Aug 08 2014 | OCUL | OCULAR THERAPEUTIX ... | CHV II, L.P. | 10% Owner | Buy | C | 0.00 | 252,525 | 0 | 252,525 | 0 to 252.5 K |
Aug 08 2014 | OCUL | OCULAR THERAPEUTIX ... | CHV II, L.P. | 10% Owner | Buy | C | 0.00 | 1,693,767 | 0 | 1,693,767 | 0 to 1.7 M |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 24,181 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 16,565 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 47,131 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 2,418,191 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 40,268 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 27,584 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 78,483 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Option Exercise | C | 0.00 | 4,026,825 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 9,159 | 0 | 24,412 | 15.3 K to 24.4 K (+60.05 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 6,275 | 0 | 16,723 | 10.4 K to 16.7 K (+60.06 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 17,853 | 0 | 47,581 | 29.7 K to 47.6 K (+60.05 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 915,981 | 0 | 2,441,293 | 1.5 M to 2.4 M (+60.05 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 15,253 | 0 | 15,253 | 0 to 15.3 K |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 10,448 | 0 | 10,448 | 0 to 10.4 K |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 29,728 | 0 | 29,728 | 0 to 29.7 K |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Polaris Venture Management Co. ... | 10% Owner | Buy | C | 0.00 | 1,525,312 | 0 | 1,525,312 | 0 to 1.5 M |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 20,804 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 3,523,039 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 14,372 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 2,433,816 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 9,563 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 1,619,102 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 1,174 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Option Exercise | C | 0.00 | 198,826 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Buy | C | 0.00 | 17,391 | 0 | 17,391 | 0 to 17.4 K |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Versant Venture Capital III, L ... | 10% Owner | Buy | C | 0.00 | 2,944,993 | 0 | 2,944,993 | 0 to 2.9 M |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Option Exercise | C | 0.00 | 42,440 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Option Exercise | C | 0.00 | 243,902 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Option Exercise | C | 0.00 | 61,664 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Option Exercise | C | 0.00 | 320,836 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | P | 13.00 | 76,922 | 999,986 | 471,784 | 394.9 K to 471.8 K (+19.48 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | C | 0.00 | 16,075 | 0 | 394,862 | 378.8 K to 394.9 K (+4.24 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | C | 0.00 | 213,915 | 0 | 846,377 | 632.5 K to 846.4 K (+33.82 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Sawhney Amarpreet | President and CEO | Buy | C | 0.00 | 23,357 | 0 | 487,242 | 463.9 K to 487.2 K (+5.04 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Chadha Jaswinder | Director | Option Exercise | C | 0.00 | 117,243 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Chadha Jaswinder | Director | Option Exercise | C | 0.00 | 27,144 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Chadha Jaswinder | Director | Option Exercise | C | 0.00 | 100,000 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Chadha Jaswinder | Director | Buy | C | 0.00 | 92,570 | 0 | 130,448 | 37.9 K to 130.4 K (+244.39 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | LINDSTROM RICHARD L MD | Director | Option Exercise | C | 0.00 | 50,000 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | LINDSTROM RICHARD L MD | Director | Buy | C | 0.00 | 18,939 | 0 | 18,939 | 0 to 18.9 K |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | C | 0.00 | 20,804 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | C | 0.00 | 3,523,039 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | C | 0.00 | 14,372 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | C | 0.00 | 2,433,816 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | C | 0.00 | 9,563 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | C | 0.00 | 1,619,102 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | C | 0.00 | 1,174 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Option Exercise | C | 0.00 | 198,826 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Buy | C | 0.00 | 17,391 | 0 | 17,391 | 0 to 17.4 K |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | Warden Charles M | Director | Buy | C | 0.00 | 2,944,993 | 0 | 2,944,993 | 0 to 2.9 M |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,172,889 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 680,722 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 493,534 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,172,889 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 680,722 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 493,534 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 32,379 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 18,793 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 13,625 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 1,140,510 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 661,929 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Option Exercise | C | 0.00 | 479,909 | 0 | 0 | |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Buy | P | 13.00 | 6,583 | 85,579 | 71,381 | 64.8 K to 71.4 K (+10.16 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Buy | P | 13.00 | 231,877 | 3,014,401 | 2,514,226 | 2.3 M to 2.5 M (+10.16 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Buy | P | 13.00 | 238,460 | 3,099,980 | 2,585,607 | 2.3 M to 2.6 M (+10.16 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Buy | P | 13.00 | 238,460 | 3,099,980 | 2,585,607 | 2.3 M to 2.6 M (+10.16 %) |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Buy | C | 0.00 | 64,798 | 0 | 64,798 | 0 to 64.8 K |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Buy | C | 0.00 | 2,282,349 | 0 | 2,282,349 | 0 to 2.3 M |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Buy | C | 0.00 | 2,347,147 | 0 | 2,347,147 | 0 to 2.3 M |
Jul 31 2014 | OCUL | OCULAR THERAPEUTIX ... | SVLSF IV, LLC | 10% Owner | Buy | C | 0.00 | 2,347,147 | 0 | 2,347,147 | 0 to 2.3 M |